Display options
Share it on

Cardiovasc Diagn Ther. 2016 Aug;6(4):354-67. doi: 10.21037/cdt.2015.12.02.

Future imaging of atherosclerosis: molecular imaging of coronary atherosclerosis with (18)F positron emission tomography.

Cardiovascular diagnosis and therapy

Daniel J Scherer, Peter J Psaltis

Affiliations

  1. Vascular Research Centre, Heart Health Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia 5000, Australia;; Royal Adelaide Hospital, South Australia 5000, Australia; ; School of Medicine, The University of Adelaide, South Australia 5000, Australia.

PMID: 27500093 PMCID: PMC4960068 DOI: 10.21037/cdt.2015.12.02

Abstract

Atherosclerosis is characterized by the formation of complex atheroma lesions (plaques) in arteries that pose risk by their flow-limiting nature and propensity for rupture and thrombotic occlusion. It develops in the context of disturbances to lipid metabolism and immune response, with inflammation underpinning all stages of plaque formation, progression and rupture. As the primary disease process responsible for myocardial infarction, stroke and peripheral vascular disease, atherosclerosis is a leading cause of morbidity and mortality on a global scale. A precise understanding of its pathogenic mechanisms is therefore critically important. Integral to this is the role of vascular wall imaging. Over recent years, the rapidly evolving field of molecular imaging has begun to revolutionize our ability to image beyond just the anatomical substrate of vascular disease, and more dynamically assess its pathobiology. Nuclear imaging by positron emission tomography (PET) can target specific molecular and biological pathways involved in atherosclerosis, with the application of (18)Fluoride PET imaging being widely studied for its potential to identify plaques that are vulnerable or high risk. In this review, we discuss the emergence of (18)Fluoride PET as a promising modality for the assessment of coronary atherosclerosis, focusing on the strengths and limitations of the two main radionuclide tracers that have been investigated to date: 2-deoxy-2-((18)F)fluoro-D-glucose ((18)F-FDG) and sodium (18)F-fluoride ((18)F-NaF).

Keywords: Coronary artery disease (CAD); cardiac imaging techniques; coronary vessels; fluorodeoxyglucose F18; molecular imaging; positron emission tomography (PET)

References

  1. J Nucl Cardiol. 2008 Mar-Apr;15(2):209-17 - PubMed
  2. Circulation. 2008 Jun 3;117(22):2938-48 - PubMed
  3. Nat Commun. 2015 Jul 07;6:7495 - PubMed
  4. N Engl J Med. 2007 Mar 29;356(13):1304-16 - PubMed
  5. J Nucl Med. 2011 Jul;52(7):1020-7 - PubMed
  6. J Nucl Med. 2011 Mar;52(3):362-8 - PubMed
  7. Tex Heart Inst J. 2010;37(3):324-7 - PubMed
  8. J Nucl Med. 2011 Nov;52(11):1698-703 - PubMed
  9. Nat Rev Immunol. 2010 Jan;10(1):36-46 - PubMed
  10. J Nucl Med. 2012 Jan;53(1):55-8 - PubMed
  11. J Am Coll Cardiol. 1994 Mar 1;23(3):809-13 - PubMed
  12. J Am Coll Cardiol. 2007 Aug 28;50(9):892-6 - PubMed
  13. Eur J Nucl Med Mol Imaging. 2003 Feb;30(2):267-73 - PubMed
  14. Nucl Med Commun. 2001 Jul;22(7):747-53 - PubMed
  15. Proc Natl Acad Sci U S A. 1995 Jan 17;92(2):402-6 - PubMed
  16. Stroke. 2014 Dec;45(12):3561-6 - PubMed
  17. AJR Am J Roentgenol. 2014 Aug;203(2):263-71 - PubMed
  18. J Intern Med. 2008 May;263(5):517-27 - PubMed
  19. Atherosclerosis. 2010 Jul;211(1):136-40 - PubMed
  20. J Nucl Med. 1995 Jul;36(7):1301-6 - PubMed
  21. Circ Cardiovasc Imaging. 2010 Sep;3(5):536-41 - PubMed
  22. J Am Coll Cardiol. 2011 Aug 2;58(6):603-14 - PubMed
  23. EuroIntervention. 2009 Jun;5(2):177-89 - PubMed
  24. Circulation. 1995 Oct 15;92 (8):2157-62 - PubMed
  25. Ann Neurol. 2012 May;71(5):709-18 - PubMed
  26. Microcirculation. 2003 Jun;10(3-4):247-57 - PubMed
  27. Circulation. 2002 Jun 11;105(23 ):2708-11 - PubMed
  28. Int J Cardiovasc Imaging. 2009 Mar;25(3):251-7 - PubMed
  29. J Nucl Med. 2015 Jul;56(7):1019-23 - PubMed
  30. Int J Cardiovasc Imaging. 2014 Feb;30(2):439-47 - PubMed
  31. Arterioscler Thromb Vasc Biol. 2000 May;20(5):1262-75 - PubMed
  32. J Nucl Cardiol. 2013 Aug;20(4):569-77 - PubMed
  33. Semin Nucl Med. 2001 Jan;31(1):28-49 - PubMed
  34. Circ Res. 2012 Jul 6;111(2):231-44 - PubMed
  35. N Engl J Med. 2006 Feb 9;354(6):610-21 - PubMed
  36. Am J Nucl Med Mol Imaging. 2012;2(4):432-47 - PubMed
  37. Curr Opin Lipidol. 2014 Oct;25(5):327-32 - PubMed
  38. Radiat Prot Dosimetry. 2010 Apr-May;139(1-3):208-13 - PubMed
  39. Circ Res. 2009 Jan 30;104(2):210-8, 21p following 218 - PubMed
  40. J Nucl Med. 2001 Jul;42(7):1091-100 - PubMed
  41. JACC Cardiovasc Imaging. 2011 Nov;4(11):1195-205 - PubMed
  42. J Nucl Med. 2010 Jun;51(6):862-5 - PubMed
  43. Atherosclerosis. 2014 Jun;234(2):276-82 - PubMed
  44. Eur J Nucl Med Mol Imaging. 2012 Mar;39(3):399-407 - PubMed
  45. J Nucl Med. 1962 Jul;3:332-4 - PubMed
  46. PLoS One. 2014 Jul 23;9(7):e99441 - PubMed
  47. J Nucl Med. 2004 Jan;45(1):124-8 - PubMed
  48. Radiol Clin North Am. 2007 Jul;45(4):735-44, viii - PubMed
  49. Hell J Nucl Med. 2011 May-Aug;14 (2):114-20 - PubMed
  50. Cell Mol Life Sci. 2013 Oct;70(20):3847-69 - PubMed
  51. Lancet. 2014 Feb 22;383(9918):705-13 - PubMed
  52. Circulation. 2008 Jun 24;117(25):3227-37 - PubMed
  53. J Am Coll Cardiol. 2015 Apr 7;65(13):1273-82 - PubMed
  54. Eur J Nucl Med. 1999 Apr;26(4):333-41 - PubMed
  55. Circulation. 1996 Sep 1;94(5):1175-92 - PubMed
  56. Nucl Instrum Methods Phys Res A. 2011 Aug 21;648 Supplement 1:S236-S240 - PubMed
  57. Physiol Rev. 2012 Apr;92(2):897-965 - PubMed
  58. Lancet. 2011 Oct 29;378(9802):1547-59 - PubMed
  59. J Nucl Med. 1978 Oct;19(10):1154-61 - PubMed
  60. J Am Coll Cardiol. 2013 Sep 3;62(10 ):909-17 - PubMed
  61. J Nucl Med. 2014 Oct;55(10 ):1629-35 - PubMed
  62. Ann Nucl Med. 2013 Jun;27(5):481-6 - PubMed
  63. PET Clin. 2014 Oct;9(4):355-70, v - PubMed
  64. Circ Res. 2011 May 27;108(11):1381-91 - PubMed
  65. J Nucl Med. 1992 Nov;33(11):1972-80 - PubMed
  66. Radiographics. 1999 Jan-Feb;19(1):61-77; quiz 150-1 - PubMed
  67. Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1506-16 - PubMed
  68. BMC Nucl Med. 2006 May 25;6:3 - PubMed
  69. Circulation. 1994 Oct;90(4):2126-46 - PubMed
  70. JACC Cardiovasc Imaging. 2010 Apr;3(4):388-97 - PubMed
  71. Proc Natl Acad Sci U S A. 2006 Jul 5;103(27):10340-5 - PubMed
  72. J Am Coll Cardiol. 2006 Nov 7;48(9):1818-24 - PubMed
  73. J Am Coll Cardiol. 2015 Apr 7;65(13):1283-5 - PubMed
  74. Rheumatology (Oxford). 1999 May;38(5):444-7 - PubMed
  75. J Am Coll Cardiol. 2012 Dec 25;60(25 Suppl):S1-49 - PubMed
  76. J Intern Med. 2015 Nov;278(5):462-82 - PubMed
  77. Circulation. 2002 Aug 6;106(6):752-6 - PubMed
  78. Nucl Med Commun. 2012 Jan;33(1):14-20 - PubMed
  79. Radiology. 2007 Jul;244(1):39-47 - PubMed
  80. Atherosclerosis. 2013 Jul;229(1):124-9 - PubMed
  81. Br Heart J. 1993 May;69(5):377-81 - PubMed
  82. J Nucl Cardiol. 2014 Apr;21(2):293-304 - PubMed
  83. Semin Ultrasound CT MR. 2008 Aug;29(4):232-5 - PubMed
  84. J Nucl Cardiol. 2011 Dec;18(6):1066-75 - PubMed
  85. JACC Cardiovasc Imaging. 2011 Dec;4(12 ):1294-301 - PubMed
  86. Arterioscler Thromb Vasc Biol. 2007 Aug;27(8):1820-7 - PubMed
  87. Clin Nucl Med. 2001 Apr;26(4):314-9 - PubMed
  88. J Nucl Med. 2009 Jun;50(6):959-65 - PubMed
  89. Circ Cardiovasc Imaging. 2014 Mar;7(2):371-8 - PubMed
  90. Eur J Nucl Med. 1996 Oct;23 (10 ):1409-15 - PubMed
  91. Semin Nucl Med. 2002 Jan;32(1):70-6 - PubMed
  92. J Intern Med. 2015 Nov;278(5):483-93 - PubMed
  93. J Am Coll Cardiol. 2008 Apr 1;51(13):1258-65 - PubMed
  94. Clin Nucl Med. 2001 Jan;26(1):68-9 - PubMed
  95. J Nucl Med. 2004 Jul;45(7):1245-50 - PubMed
  96. J Neurol Sci. 2014 Dec 15;347(1-2):242-5 - PubMed
  97. J Atheroscler Thromb. 2006 Feb;13(1):31-7 - PubMed
  98. Circ Res. 2005 Jun 24;96(12):1248-56 - PubMed
  99. J Comput Assist Tomogr. 1999 Jan-Feb;23 (1):16-8 - PubMed
  100. J Am Coll Cardiol. 2012 Apr 24;59(17 ):1539-48 - PubMed
  101. Circulation. 2007 Dec 11;116(24):2841-50 - PubMed
  102. Mediators Inflamm. 2013;2013:714653 - PubMed
  103. Biochem Biophys Res Commun. 1999 Oct 5;263(3):804-9 - PubMed

Publication Types